FDA APPROVES EYLEA® (AFLIBERCEPT) INJECTION PREFILLED SYRINGE
TARRYTOWN, N.Y., Aug. 13, 2019 /PRNewswire/ — EYLEA is the only anti-VEGF approved to treat four retinal conditions with a single dose strength prefilled syringe EYLEA is available in multiple dosing intervals,…